7
Participants
Start Date
February 25, 2018
Primary Completion Date
March 29, 2019
Study Completion Date
March 29, 2019
CX-8998
T-type calcium channel blocker
NYU Comprehensive Epilepsy Center, New York
Thomas Jefferson University, Philadelphia
University of Florida, Tampa
Bluegrass Epilepsy Research, LLC, Lexington
Cincinnati Children's Hospital, Cincinnati
Arkansas Epilepsy Program, Little Rock
Tufts Medical Center, Boston
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY